Botanical species · safety record

Brassica rapa

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Brassica rapa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brassica rapa L.

6Constituent measurements

1Safety records

3Cited sources

16Licensed products (Canada)

Also recorded as

Brassica campestris L.
Brassica pekinensis Skeels
Brassica pekinensis (Lour.) Rupr.
Brasica rapa subsp. Rapa
Brassica rapa subsp. pekinensis (Lour.) Kitam.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 16 licensed products naming Brassica rapa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Aerial parts
Leaf
Leaves
Root

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Unspecified	Solvent extraction	0.7 Percent	Phytochemical screening	No resolvable identifier
Cyanide	Unspecified	Solvent extraction	0.5 Percent	Phytochemical screening	No resolvable identifier
Oxalates	Unspecified	Solvent extraction	0.6 Percent	Phytochemical screening	No resolvable identifier
Saponins	Unspecified	Solvent extraction	4 Percent	Phytochemical screening	No resolvable identifier
Sum of glucosinolates	Aerial part of plants	Solvent extraction	≥ 2.7 Millimole/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Sum of glucosinolates	Aerial part of plants	Solvent extraction	≤ 57.88 Millimole/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Liver	Aerial part of plants	—	Cattle (as animal)	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Collett, Mark G., Stegelmeier, Bryan L., Tapper, Brian A. Could Nitrile Derivatives of Turnip (Brassica rapa) Glucosinolates Be Hepato- or Cholangiotoxic in Cattle? . Journal of agricultural and food chemistry, 2014, vol. 62, no. 30, p. 7370-7375. DOI
Khan, Zafar Iqbal., Ahmad, Kafeel., Zafar, Asma., Bashir, Humayun., Hussain, Abrar., Huma, Zile., Shad, Hazoor Ahmad., Sher, Muhammad., Hussain, Ghulam., Noorka, Ijaz Rasool., . Assessment of poisonous and anti-nutritional compounds in wild edible forages consumed by ruminant species. Journal of environmental science and technology, 2015, vol. 8, no. 3, p. 91-101.
Chun, Jin-Hyuk., Kim, Na-Hyung., Seo, Mi-Suk., Jin, Mina., Park, Sang Un., Arasu, Mariadhas Valan., Kim, Sun-Ju., Al-Dhabi, Naif Abdullah. Molecular characterization of glucosinolates and carotenoid biosynthetic genes in Chinese cabbage (Brassica rapa L. ssp. pekinensis). Saudi journal of biological sciences, 2016, p. Ahead of Print.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature